ピーク情報
|
パセリ 葉
pos
|
| Peak #9994 MN MID: SE61_S21_M90 |
| m/z: 373.17754, RT: 90.32, 強度: 15586, ログ強度: 0.61, アダクト: [M+K]+, 共有数（同様のピークを含むサンプル数）: 2 |
| DB検索結果: (154 names) bicyclo-PGE2;(+)-Phomactin F;Phomactin F;5R-hydroxy-11-oxo-6E,14Z,12-prostatrienoic acid-cyclo[8S,12R];1-(3,3-Dimethyloxiranyl)-7-hydroxy-3,7-dimethyl-3,5,8-nonatrienyl ester 2-methyl-2-butenoic acid;... |
| DBごとのヒット数: ALL 128 KG 14 KN 74 HM 4 LM 36 |
| FlavonoidSearch最大スコア MS2: 0.039, MS3: - |
DB検索結果
ppm
| 組成式 | 分子量 | 誤差(Δppm） | 候補化合物名（代表で最短名を記載） | 化合物ID |
|---|---|---|---|---|
| C20H30O4 | 334.21441 | -0.087 | bicyclo-PGE2 | HMDB: HMDB0060054, HMDB0249187 LipidMAPS: LMFA03010034 |
| C20H30O4 | 334.21441 | -0.087 | (+)-Phomactin F | KNApSAcK: C00016598 |
| C20H30O4 | 334.21441 | -0.087 | 5R-hydroxy-11-oxo-6E,14Z,12-prostatrienoic acid-cyclo[8S,12R] | LipidMAPS: LMFA03110071, LMFA03110072, LMFA03110073, LMFA03110074 |
| C20H30O4 | 334.21441 | -0.087 | 1-(3,3-Dimethyloxiranyl)-7-hydroxy-3,7-dimethyl-3,5,8-nonatrienyl ester 2-methyl-2-butenoic acid | KNApSAcK: C00011418 |
| C20H30O4 | 334.21441 | -0.087 | Lapidin | KNApSAcK: C00021406 |
| C20H30O4 | 334.21441 | -0.087 | 9-oxo-11R-hydroxy-5Z,13E-prostadienoic acid-1,15S-lactone | LipidMAPS: LMFA03010198 |
| C20H30O4 | 334.21441 | -0.087 | 12R,13R-dihydroxy-eicosa-5Z,8Z,10E,14Z,17Z-pentaenoic acid | LipidMAPS: LMFA03070060 |
| C20H30O4 | 334.21441 | -0.087 | Leoheteronin E | KNApSAcK: C00031965 |
| C20H30O4 | 334.21441 | -0.087 | Resolvin E3 | HMDB: HMDB0257164 LipidMAPS: LMFA03140006, LMFA03140007 |
| C20H30O4 | 334.21441 | -0.087 | Delta-12-Prostaglandin J2 | HMDB: HMDB0004238, HMDB0247550 KEGG: C05958 LipidMAPS: LMFA03010020 |
| C20H30O4 | 334.21441 | -0.087 | 14,15-epoxy-13-hydroxy-5Z,8Z,11Z,17Z-eicosatetraenoic acid | LipidMAPS: LMFA03060117 |
| C20H30O4 | 334.21441 | -0.087 | Pachyclavulariolide N | KNApSAcK: C00044990, C00044991 |
| C20H30O4 | 334.21441 | -0.087 | Resolvin E2 | HMDB: HMDB0257163 KEGG: C18173 LipidMAPS: LMFA03140004, LMFA03140011 |
| C20H30O4 | 334.21441 | -0.087 | (5Z,8Z,11Z)-12-{(1'R,2'S,3'S,5'S)-3-[(1''E)-1''-hydroxypropyl]-6'-oxabicyclo[3.1.0]hex-2'-yl}-5,8,11-dodecatrienoic acid | LipidMAPS: LMFA04000105 |
| C20H30O4 | 334.21441 | -0.087 | Acanthokoreoic acid A | KNApSAcK: C00031557 |
| C20H30O4 | 334.21441 | -0.087 | Kolavic acid | KNApSAcK: C00023484, C00023486 |
| C20H30O4 | 334.21441 | -0.087 | ent-16-Hydroxy-17-oxo-7,13Z-Labdadiene-15-oic acid | KNApSAcK: C00022741 |
| C20H30O4 | 334.21441 | -0.087 | Sinulariolide | KNApSAcK: C00040316 |
| C20H30O4 | 334.21441 | -0.087 | Preleoheterin | KNApSAcK: C00035728 |
| C20H30O4 | 334.21441 | -0.087 | ent-8beta,17-Epoxy-3-oxo-13Z-labden-15-oic acid | KNApSAcK: C00022516 |
| C20H30O4 | 334.21441 | -0.087 | Agathic acid | HMDB: HMDB0036828, HMDB0248058 KNApSAcK: C00022522, C00022526, C00041322 |
| C20H30O4 | 334.21441 | -0.087 | 7'-Carboxy-gamma-chromanol | HMDB: HMDB0012850 |
| C20H30O4 | 334.21441 | -0.087 | Prostaglandin A2 | HMDB: HMDB0002752, HMDB0242292, HMDB0302203 KEGG: C05953 LipidMAPS: LMFA03010035, LMFA03010092, LMFA03010100, LMFA03110137, LMFA03110138, LMFA03110139, LMFA03110140, LMFA03110141, LMFA03110142 |
| C20H30O4 | 334.21441 | -0.087 | 8,9-epoxy-7-hydroxy-5Z,11Z,14Z,17Z-eicosatetraenoic acid | LipidMAPS: LMFA03060116 |
| C20H30O4 | 334.21441 | -0.087 | Alboatisin C | KNApSAcK: C00038400 |
| C20H30O4 | 334.21441 | -0.087 | 12R-hydroxy-8-oxo-6,10E,14Z-prostatrienoic acid-cyclo[5R,9R] | LipidMAPS: LMFA03110086, LMFA03110087, LMFA03110088, LMFA03110089, LMFA03110272, LMFA03110273, LMFA03110274, LMFA03110275 |
| C20H30O4 | 334.21441 | -0.087 | 15S-hydroperoxy-5Z,8Z,11Z,13E,17Z-eicosapentaenoic acid | LipidMAPS: LMFA03070013 |
| C20H30O4 | 334.21441 | -0.087 | Vaginatin | HMDB: HMDB0035286 KNApSAcK: C00021410 |
| C20H30O4 | 334.21441 | -0.087 | Prostaglandin B2 | HMDB: HMDB0004236, HMDB0302205 KEGG: C05954 LipidMAPS: LMFA03010018, LMFA03010235 |
| C20H30O4 | 334.21441 | -0.087 | Sch 49027 | KNApSAcK: C00016813 |
| C20H30O4 | 334.21441 | -0.087 | Prostaglandin C2 | HMDB: HMDB0060095 KEGG: C05955 LipidMAPS: LMFA03010133 |
| C20H30O4 | 334.21441 | -0.087 | Dihydrocapsiconiate | KNApSAcK: C00033774 |
| C20H30O4 | 334.21441 | -0.087 | 14,15-epoxy-16-hydroxy-5Z,8Z,11Z,17Z-eicosapentaenoic acid | LipidMAPS: LMFA03060115 |
| C20H30O4 | 334.21441 | -0.087 | Crassocolide D | KNApSAcK: C00041458 |
| C20H30O4 | 334.21441 | -0.087 | Caesalpinolide D | KNApSAcK: C00048342 |
| C20H30O4 | 334.21441 | -0.087 | Leoheterin | KNApSAcK: C00031960 |
| C20H30O4 | 334.21441 | -0.087 | Topsentolide B1 | KNApSAcK: C00041940 |
| C20H30O4 | 334.21441 | -0.087 | 14-hydroperoxy-5Z,8Z,11Z,15E,17Z-eicosapentaenoic acid | LipidMAPS: LMFA03070056 |
| C20H30O4 | 334.21441 | -0.087 | 15-Keto-13,14-dihydroprostaglandin A2 | HMDB: HMDB0001244 LipidMAPS: LMFA03010033 |
| C20H30O4 | 334.21441 | -0.087 | Phlogantholide A | KNApSAcK: C00022230 |
| C20H30O4 | 334.21441 | -0.087 | Flexibilide | KNApSAcK: C00039215 |
| C20H30O4 | 334.21441 | -0.087 | (S,5Z,9E)-8-hydroxy-10-((1S,5R)-2-oxo-5-pentylcyclopent-3-en-1-yl)deca-5,9-dienoic acid | LipidMAPS: LMFA03110263, LMFA03110264, LMFA03110265, LMFA03110266, LMFA03110267, LMFA03110268, LMFA03110269, LMFA03110270 |
| C20H30O4 | 334.21441 | -0.087 | 1(10),13E-Halimadiene-15,18-dioic acid | KNApSAcK: C00023449, C00023451 |
| C20H30O4 | 334.21441 | -0.087 | 16-Hydroxy-6-oxo-7,ent-13E-labdasien-15-oic acid | KNApSAcK: C00022430 |
| C20H30O4 | 334.21441 | -0.087 | Isodopharicin D | KNApSAcK: C00050918 |
| C20H30O4 | 334.21441 | -0.087 | 5,6-Epoxytetraene | KEGG: C14815 LipidMAPS: LMFA03060075 |
| C20H30O4 | 334.21441 | -0.087 | Decahydro-alpha,4a-dimethyl-8-methylene-7-[(2-methyl-1-oxo-2-butenyl)oxy]-2-naphthaleneacetic acid | KNApSAcK: C00012848 |
| C20H30O4 | 334.21441 | -0.087 | Hartwrightia acid | KNApSAcK: C00022423 |
| C20H30O4 | 334.21441 | -0.087 | [4aR-(4aalpha,5alpha,6alpha,8abeta)]-4,4a,5,6,7,8,8a,9-Octahydro-5-hydroxy-3,5,8a-trimethylnaphtho[2,3-b]furan-6-yl ester3-methylbutanoic acid | KNApSAcK: C00012905 |
| C20H30O4 | 334.21441 | -0.087 | 5S-hydroxy-9-oxo-6E,10,14Z-prostatrienoic acid-cyclo[8S,12R] | LipidMAPS: LMFA03110255, LMFA03110256, LMFA03110257, LMFA03110258, LMFA03110259, LMFA03110260, LMFA03110261, LMFA03110262 |
| C20H30O4 | 334.21441 | -0.087 | Cymbodiacetal | KNApSAcK: C00010811 |
| C20H30O4 | 334.21441 | -0.087 | 12S-hydroperoxy-5Z,8Z,10E,14Z,17Z-eicosapentaenoic acid | LipidMAPS: LMFA03070012 |
| C20H30O4 | 334.21441 | -0.087 | Neoallocyathin A4 | KNApSAcK: C00023685 |
| C20H30O4 | 334.21441 | -0.087 | 14-Deoxyandrographolide | HMDB: HMDB0244579 KNApSAcK: C00022232 |
| C20H30O4 | 334.21441 | -0.087 | (R,E)-5-hydroxy-7-((R,E)-2-((Z)-oct-2-en-1-ylidene)-3-oxocyclopentyl)hept-6-enoic acid | LipidMAPS: LMFA03110276, LMFA03110277, LMFA03110278, LMFA03110279 |
| C20H30O4 | 334.21441 | -0.087 | Serrulat-14-en-3,7,8,20-tetraol | KNApSAcK: C00040283 |
| C20H30O4 | 334.21441 | -0.087 | 12,18-dihydroxy-5Z,8Z,10E,14Z,16E-eicosapentaenoic acid | LipidMAPS: LMFA03070051 |
| C20H30O4 | 334.21441 | -0.087 | 12-Keto-leukotriene B4 | HMDB: HMDB0004234 KEGG: C05949 LipidMAPS: LMFA03020024 |
| C20H30O4 | 334.21441 | -0.087 | Mebadonin | KNApSAcK: C00051518 |
| C20H30O4 | 334.21441 | -0.087 | Leukotriene B5 | HMDB: HMDB0005073, HMDB0062486, HMDB0247478 LipidMAPS: LMFA03020010 |
| C20H30O4 | 334.21441 | -0.087 | Leopersin G | KNApSAcK: C00050374 |
| C20H30O4 | 334.21441 | -0.087 | Mayolide A | KNApSAcK: C00042722 |
| C20H30O4 | 334.21441 | -0.087 | Hallerin | KNApSAcK: C00012174 |
| C20H30O4 | 334.21441 | -0.087 | 9S-hydroperoxy-5Z,7E,11Z,14Z,17Z-eicosapentaenoic acid | LipidMAPS: LMFA03070057 |
| C20H30O4 | 334.21441 | -0.087 | 5-oxo-12-HETE | HMDB: HMDB0012824, HMDB0062423 LipidMAPS: LMFA03020069 |
| C20H30O4 | 334.21441 | -0.087 | 5S-hydroperoxy-6E,8Z,11Z,14Z,17Z-eicosapentaenoic acid | LipidMAPS: LMFA03070001, LMFA03070059 |
| C20H30O4 | 334.21441 | -0.087 | 7,13(16)-Labdadiene-15,19-dioic acid | KNApSAcK: C00022442 |
| C20H30O4 | 334.21441 | -0.087 | 9S,11R-dihydroxy-5Z,13E,17Z-prostatrienoic acid-1,15S-lactone | LipidMAPS: LMFA03010197 |
| C20H30O4 | 334.21441 | -0.087 | 18-Oxogrindelic acid | KNApSAcK: C00022629 |
| C20H30O4 | 334.21441 | -0.087 | Manaarenolide I | KNApSAcK: C00041657 |
| C20H30O4 | 334.21441 | -0.087 | Excoecarin V2 | KNApSAcK: C00031782 |
| C20H30O4 | 334.21441 | -0.087 | 4-((1R,2R)-2-((R,1E,5Z)-3-hydroxyundeca-1,5-dien-1-yl)-5-oxocyclopent-3-en-1-yl)butanoic acid | LipidMAPS: LMFA03110247, LMFA03110248, LMFA03110249, LMFA03110250, LMFA03110251, LMFA03110252, LMFA03110253, LMFA03110254 |
| C20H30O4 | 334.21441 | -0.087 | 3,4-Dihexylphthalic Acid | HMDB: HMDB0258114 |
| C20H30O4 | 334.21441 | -0.087 | Floridicin | KNApSAcK: C00047045 |
| C20H30O4 | 334.21441 | -0.087 | 17beta-Hydroxy-4-oxa-5alpha-androstan-3-one acetate | KEGG: C14913 |
| C20H30O4 | 334.21441 | -0.087 | Manaarenolide G | KNApSAcK: C00041655, C00041656 |
| C20H30O4 | 334.21441 | -0.087 | 5S,12R-dihydroxy-6Z,8E,10E-eicosatriene-14-ynoic acid | LipidMAPS: LMFA03020017 |
| C20H30O4 | 334.21441 | -0.087 | 9-[(1R,2S,3S,5S)-3-[(1S,2R)-2-[(1R)-1-Hydroxypropyl]cyclopropyl]-6-oxabicyclo[3.1.0]hexan-2-yl]nona-5Z,8Z-dienoic acid | LipidMAPS: LMFA04000095 |
| C20H30O4 | 334.21441 | -0.087 | LipidMAPS: LMPR0104090001 |
|
| C20H30O4 | 334.21441 | -0.087 | 17,18-Dihydroxy-2,6,10,14-phytatetraen-1,20-olide | KNApSAcK: C00022129, C00022130 |
| C20H30O4 | 334.21441 | -0.087 | Scapanin A | KNApSAcK: C00022258 |
| C20H30O4 | 334.21441 | -0.087 | 3-O-Angeloylcuauhtemone | KNApSAcK: C00012696 |
| C20H30O4 | 334.21441 | -0.087 | LipidMAPS: LMPR0104180004 |
|
| C20H30O4 | 334.21441 | -0.087 | 17-Oxogrindelic acid | KEGG: C09150 KNApSAcK: C00003462 |
| C20H30O4 | 334.21441 | -0.087 | Phyllostachysin F | KNApSAcK: C00034948 |
| C20H30O4 | 334.21441 | -0.087 | Excoecarin V1 | KNApSAcK: C00031781 |
| C20H30O4 | 334.21441 | -0.087 | 12,20-Dihydroxy-3alpha,4alpha,15,16-bisepoxy-8beta,10betaH-ent-cleroda-13(16),14-diene | KNApSAcK: C00022538 |
| C20H30O4 | 334.21441 | -0.087 | Phytocassane B | HMDB: HMDB0041055 KNApSAcK: C00034141 |
| C20H30O4 | 334.21441 | -0.087 | 8betaH,ent-3eta,17-Dioxo-13Z-labden-15-oic acid | KNApSAcK: C00022435, C00022437 |
| C20H30O4 | 334.21441 | -0.087 | (E,E,E)-2-(4,8,12-Trimethyl-3,7,11-tridecatrienyl)-2-butenedioic acid | KNApSAcK: C00016237 |
| C20H30O4 | 334.21441 | -0.087 | 5Z,8Z,11Z,14Z-Eicosatetraenedioic acid | LipidMAPS: LMFA01170034 |
| C20H30O4 | 334.21441 | -0.087 | Di-n-hexyl phthalate | HMDB: HMDB0251287 KEGG: C14504 |
| C20H30O4 | 334.21441 | -0.087 | Hypoglicin A | KNApSAcK: C00055916 |
| C20H30O4 | 334.21441 | -0.087 | ent-2,3-Seco-beyer-15-ene-2,3-dioic acid | KNApSAcK: C00049148 |
| C20H30O4 | 334.21441 | -0.087 | 6-Oxogrindelic acid | KNApSAcK: C00022623 |
| C20H30O4 | 334.21441 | -0.087 | Cyathin A4 | KNApSAcK: C00023678 |
| C20H30O4 | 334.21441 | -0.087 | 5S,15S-dihydroxy-6E,8Z,11Z,13E,17Z-eicosapentaenoic acid | LipidMAPS: LMFA03140013 |
| C20H30O4 | 334.21441 | -0.087 | Zerumin B | KNApSAcK: C00043123 |
| C20H30O4 | 334.21441 | -0.087 | Batudioic acid | KNApSAcK: C00022441 |
| C20H30O4 | 334.21441 | -0.087 | 8R-HPETE | KNApSAcK: C00000422 |
| C20H30O4 | 334.21441 | -0.087 | (ent-16betaOH)-16,17-Dihydroxy-9(11)-kauren-19-oic acid | HMDB: HMDB0036760 |
| C20H30O4 | 334.21441 | -0.087 | Chapecoderin A | KNApSAcK: C00046662 |
| C20H30O4 | 334.21441 | -0.087 | 18R-hydroperoxy-5Z,8Z,11Z,14Z,16E-eicosapentaenoic acid | LipidMAPS: LMFA03070043 |
| C20H30O4 | 334.21441 | -0.087 | 3beta,13-Dihydroxy-16-(hydroxymethylene)-13,17-seco-5alpha-androstan-17-oic acid, delta-lactone | KEGG: C15159 |
| C20H30O4 | 334.21441 | -0.087 | Isoscoparin L | KNApSAcK: C00047259 |
| C20H30O4 | 334.21441 | -0.087 | 15d PGD2 | HMDB: HMDB0060046, HMDB0062298 LipidMAPS: LMFA03010051 |
| C20H30O4 | 334.21441 | -0.087 | 8,18-dihydroxy-5Z,9E,11Z,14Z,16E-eicosapentaenoic acid | LipidMAPS: LMFA03070052 |
| C20H30O4 | 334.21441 | -0.087 | Phomactin A | KNApSAcK: C00016814 |
| C20H30O4 | 334.21441 | -0.087 | Enanderianin P | KNApSAcK: C00030178 |
| C20H30O4 | 334.21441 | -0.087 | Prostaglandin J2 | HMDB: HMDB0002710, HMDB0247117 KEGG: C05957 LipidMAPS: LMFA03010019, LMFA03110100, LMFA03110101, LMFA03110102, LMFA03110103, LMFA03110114, LMFA03110133, LMFA03110135 |
| C20H30O4 | 334.21441 | -0.087 | ent-2alpha-2,18-Dihydroxy-8(17),13-labdadien-15,16-olide | KNApSAcK: C00022229 |
| C20H30O4 | 334.21441 | -0.087 | 3alpha,12-Dihydroxy-4alpha,20,15,16-bisepoxy-8beta,10betaH-ent-cleroda-13(16),14-diene | KNApSAcK: C00022539 |
| C20H30O4 | 334.21441 | -0.087 | Pseurata A | KNApSAcK: C00047547, C00047616 |
| C20H30O4 | 334.21441 | -0.087 | 3-Oxo-18-hydroxy-8(17),13Z-labdadien-15-oic acid | KNApSAcK: C00022492 |
| C20H30O4 | 334.21441 | -0.087 | Cyafrin A4 | KNApSAcK: C00023686 |
| C20H30O4 | 334.21441 | -0.087 | 6beta,7beta-Dihydroxykaurenoic acid | HMDB: HMDB0036763 KEGG: C11876 |
| C20H30O4 | 334.21441 | -0.087 | 8R-hydroxy-14-oxo-5Z,9E,12-prostatrienoic acid-cyclo[11S,15R] | LipidMAPS: LMFA03110058, LMFA03110059, LMFA03110060, LMFA03110061, LMFA03110280, LMFA03110281, LMFA03110282, LMFA03110283 |
| C20H30O4 | 334.21441 | -0.087 | LipidMAPS: LMPR0104480003 |
|
| C20H30O4 | 334.21441 | -0.087 | [R-[R*,R*-(Z,E,E,E)]]-1-(3,3-Dimethyloxiranyl)-9-hydroxy-3,7-dimethyl-3,5,7-nonatrienyl ester 2-methyl-2-butenoic acid | KNApSAcK: C00011419 |
| C20H30O4 | 334.21441 | -0.087 | 8alpha-8-Hydroxy-12-oxo-13-abieten-18-oic acid | HMDB: HMDB0035878 |
| C20H30O4 | 334.21441 | -0.087 | 9S,15S-dihydroxy-5Z,7E,11Z,13E,17Z-eicosapentaenoic acid | LipidMAPS: LMFA03070061 |
| C20H30O4 | 334.21441 | -0.087 | Decahydro-alpha,4a-dimethyl-8-methylene-7-[(3-methyl-1-oxo-2-butenyl)oxy]-2-naphthaleneacetic acid | KNApSAcK: C00012847 |
| C20H30O4 | 334.21441 | -0.087 | LipidMAPS: LMPR0104310001 |
|
| C20H30O4 | 334.21441 | -0.087 | Henrilabdane C | KNApSAcK: C00033909 |
| C20H30O4 | 334.21441 | -0.087 | Chapecoderin B | KNApSAcK: C00046663 |
| C20H30O4 | 334.21441 | -0.087 | Kamebanin | KNApSAcK: C00047260, C00047479 |
| C20H30O4 | 334.21441 | -0.087 | Caesalpinolide C | KNApSAcK: C00048341 |
| C20H30O4 | 334.21441 | -0.087 | 11,18-dihydroxy-5Z,8Z,12E,14Z,16E-eicosapentaenoic acid | LipidMAPS: LMFA03070050 |
| C20H30O4 | 334.21441 | -0.087 | Sandensolide | KNApSAcK: C00050213 |
| C20H30O4 | 334.21441 | -0.087 | Lathyrol | KEGG: C09125 KNApSAcK: C00003450 |
MSnスペクトル情報
| Level: 2, プリカーサーm/z: 373.17709 |
| Splash: splash10-0pb9-0129000000-db593b647c603f722d94 |
| m/z | Int. | NL | Rel.Int. |
|---|---|---|---|
| 355.34 | 330 | 18 | 1000 |
| 354.56 | 291 | 19 | 881 |
| 273.13 | 171 | 100 | 516 |
| 326.16 | 116 | 47 | 350 |
| 357.02 | 71 | 16 | 215 |
| 356.14 | 68 | 17 | 206 |
| 299.12 | 57 | 74 | 173 |
| 187.15 | 49 | 186 | 148 |
| 291.16 | 48 | 82 | 145 |
| 138.95 | 41 | 234 | 123 |
| 337.48 | 36 | 36 | 110 |
| 310.86 | 36 | 62 | 107 |
| 315.13 | 30 | 58 | 90 |
| 202.25 | 28 | 171 | 83 |
| 363.38 | 27 | 10 | 83 |
| 239.01 | 25 | 134 | 75 |
| 173.01 | 24 | 200 | 73 |
| 131.22 | 23 | 242 | 70 |
| 331.24 | 23 | 42 | 69 |
| 153.15 | 23 | 220 | 68 |
FlavonoidSearch結果
| Score | Symbolized Name | MSMS-Category | MSMS-Aglycone |
|---|---|---|---|
| 0.081 | [Isoflavone]-A(2OMe)-B(3OMe) | Isoflavone | 6,7,3',4',5'-Pentamethoxyisoflavone |
| 0.081 | [Isoflavone]-A(2OMe)-B(3OMe) | Isoflavone | 6,7,2',3',4'-Pentamethoxyisoflavone |
| 0.081 | [Isoflavone]-A(2OMe)-B(3OMe) | Isoflavone | 6,7,2',4',5'-Pentamethoxyisoflavone |
| 0.081 | [Isoflavone]-A(2OMe)-B(3OMe) | Isoflavone | Robustigenin methyl ether |
| 0.040 | [Flavone]-A(2OMe)-B(3OMe) | Flavone | Prosogerin C |
| 0.040 | [Flavone]-A(2OMe)-B(3OMe) | Flavone | 7,8,3',4',5'-Pentamethoxyflavone |
| 0.040 | [Flavone]-A(2OMe)-B(3OMe) | Flavone | 5,6,2',3',6'-Pentamethoxyflavone |
| 0.040 | [Flavone]-A(2OMe)-B(3OMe) | Flavone | Cerosilin B |
| 0.040 | [Flavone]-A(2OMe)-B(3OMe) | Flavone | 5,6,2',3',4'-Pentamethoxyflavone |
| 0.040 | [Flavone]-A(2OMe)-B(3OMe) | Flavone | Tricetin 5,7,3',4',5'-pentamethyl ether |
| 0.040 | [Flavone]-A(2OMe)-B(3OMe) | Flavone | 5,7,2',3',4'-Pentamethoxyflavone |
| 0.040 | [Flavone]-A(2OMe)-B(3OMe) | Flavone | 5,7,2',4',6'-Pentamethoxyflavone |
| 0.040 | [Flavone]-A(3OMe)-B(2OMe) | Flavone | Sinensetin |
| 0.040 | [Flavone]-A(3OMe)-B(2OMe) | Flavone | Isosinensetin |
| 0.040 | [Flavone]-A(4OMe)-B(1OMe) | Flavone | Tangeretin |
| 0.032 | [Dihydroflavonol]-A(2OH, 1(C-Prenyl))-B(2OH) | Dihydroflavonol | 6-Prenyltaxifolin |
| 0.000 | [2'-Hydroxychalcone]-A(2OH)-B(1([2,3:@@]-(5-(p-Hydroxyphenyl)furano))) | 2'-Hydroxychalcone | Lophirone E |
| 0.000 | [beta-Hydroxy(or Oxodihydro)chalcone (2-OMe)]-A(1([@@]-Methylenedioxy))-B(3OMe) | beta-Hydroxy(or Oxodihydro)chalcone | 3',4'-Methylenedioxy-2,4,6,beta-tetramethoxychalcone |
| 0.000 | [Flavanone]-A(1OH)-B(1([2,3:@@]-(5-(p-Hydroxyphenyl)furano))) | Flavanone | 7-Hydroxy-(5-(p-Hydroxyphenyl)furano)[2,3:4',3'])flavanone |
| 0.000 | [Flavanone]-A(2OH, 1((E)-4-Hydroxyprenyl))-B(2OH) | Flavanone | Licoleafol |
| 0.000 | [Flavanone]-A(2OH)-B(1OH, 1([2,3:@@]-(6,6-Dimethyl-5-hydroxydihydropyrano))) | Flavanone | Sigmoidin D |
| 0.000 | [3-substituted Flavone (3-(3-Methylbutyl))]-A(2OH)-B(3OH) | 3-substituted Flavone | Asplenetin |
| 0.000 | [Flavonol (3-OMe)]-A(3OMe)-B(1OMe) | Flavonol | Auranetin |
| 0.000 | [Flavonol (3-OMe)]-A(2OMe)-B(2OMe) | Flavonol | 3,5,7,2',6'-Pentamethoxyflavone |
| 0.000 | [Flavonol]-A(2OH, 1(3-hydroxy-3-methylbutyl))-B(1OH) | Flavonol | 6-(3-hydroxy-3-methylbutyl)kaempferol |
| 0.000 | [Flavonol]-A(2OH, 1(3-hydroxy-3-methylbutyl))-B(1OH) | Flavonol | Noricaritin |
| 0.000 | [Flavonol (3-OMe)]-A(2OMe)-B(2OMe) | Flavonol | Quercetin pentamethyl ether |
| 0.000 | [Flavonol (3-OMe)]-A(1OH, 1OMe, 1Methyl)-B(2OMe) | Flavonol | 2-(3,4-Dimethoxyphenyl)-5-hydroxy-3,7-dimethoxy-6-methyl-4H-1-benzopyran-4-one |
| 0.000 | [Flavonol (3-OMe)]-A(1OH, 1OMe, 2Methyl)-B(1OH, 1OMe) | Flavonol | 5,4'-Dihydroxy-3,7,3'-trimethoxy-6,8-dimethylflavone |
| 0.000 | [Flavonol (3-OMe)]-A(1OH, 2OMe)-B(1([@@]-Methylenedioxy)) | Flavonol | Melisimplin |
| 0.000 | [Flavonol (3-OMe)]-A(3OMe)-B(1OMe) | Flavonol | Herbacetin pentamethyl ether |
| 0.000 | [Flavonol (3-OMe)]-A(1OH, 2OMe)-B(1([@@]-Methylenedioxy)) | Flavonol | 7-Hydroxy-3,5,8-trimethoxy-3',4'-methylenedioxyflavone |
| 0.000 | [Flavonol (3-OMe)]-A(1OH, 2OMe)-B(1([@@]-Methylenedioxy)) | Flavonol | 5-Hydroxy-3,7,8-trimethoxy-3',4'-methylenedioxyflavone |
| 0.000 | [Flavonol (3-OMe)]-A(4OMe)-B(none) | Flavonol | 3,5,6,7,8-Pentamethoxyflavone |
| 0.000 | [Flavan 3,4-diol]-A(1OH, 1OMe, 1(C-Prenyl))-B(1OH) | Flavan 3,4-diol | 3,4,7,4'-Tetrahydroxy-5-methoxy-8-prenylflavan |
| 0.000 | [Isoflavone]-A(2OH, 1(3-hydroxy-3-methylbutyl))-B(2OH) | Isoflavone | 2,3-Dehydrokievitone hydrate |
| 0.000 | [Isoflavanone]-A(2OH, 1((Z)-4-hydroxyprenyl))-B(2OH) | Isoflavanone | Kievitol |
| 0.000 | [6-Hydroxydehydrorotenone]-A(3OH)-B(1OH)-C(1(O-Acetyl)) | 6-Hydroxydehydrorotenone | 3,6,9,10,11-Pentahydroxydehydrorotenone 6-O-acetate |
| 0.000 | [6-Hydroxydehydrorotenone]-A(1OH, 1OMe)-B(2OMe) | 6-Hydroxydehydrorotenone | Stemonal |
関連ピーク情報
| ピーク番号 | 保持時間 (min) | m/z | m/z差分 | ログ強度 | アダクト | DB検索結果 | ヒット数 | MSn | FS2 | FS3 | N原子数 | S原子数 | 共有数 |
|---|